Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Piperlongumine
Cat. No.:
OB0225LY-0337
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and HPLC.
Size:
Product Overview
Description:
Piperlongumine is a natural alkaloid from Piper longum with potential anti-tumor properties.
Synonym:
PPLGM; Piplartine; 20069-09-4; (E)-1-(3-(3,4,5-Trimethoxyphenyl)acryloyl)-5,6-dihydropyridin-2(1H)-one; 2(1H)-Pyridinone
CAS No.:
20069-09-4
Compound CID:
637858
Formula:
C17H19NO5
Formula Weight:
317.34
Specification
Source:
Piper longum
Relative Density:
1.223 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Piperlongumine can be used in antitumor drug screening studies or play an important role in molecular pharmacology studies.
Library Information
Targets:
ROS; ERK; Reactive oxygen species
Pathways:
Microbiology/Virology; MAPK; Autophagy; Immunology/Inflammation; Metabolism; Apoptosis; NF-κB
Plate Number:
AOCL-5
Plate Location:
c11
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
16.67 mg/mL; 52.52 mM
ALogP:
2.135
HBA_Count:
5
HBD_Count:
0
Rotatable Bond:
5
